GET THE APP

Perspectives of colorectal cancer screening and early clinical diagnosis
..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Perspectives of colorectal cancer screening and early clinical diagnosis


3rd World Congress on Cancer Science & Therapy

October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Hong-Hong (Helen) Zhu

Accepted Abstracts: J Cancer Sci Ther

Abstract :

This lecture will address perspectives of colorectal cancer screening and early clinical diagnosis. Prevention and early diagnosis of CRC through mass screening is important and practical against CRC. Low compliance for current screening tests affects the effectiveness of CRC mass screening. An efficient screening protocol with high compliance is needed for CRC mass screening. Systematic searches were done through Medline and Cochrane Library databases. This review explored the current CRC mass screening protocols to find a more efficient and practical mass screening protocol and problems suitable for further research. Considering the current economic crisis and limited available resources, combination of high risk factor questionnaire and immunochemical fecal occult blood test approach as primary CRC mass screening can currently be used as a risk stratification tool to identify high-risk populations from the community, especially for medically and economically underserved areas/countries before a new better test comes. Using serum pyruvate kinase isoenzyme M2 (M2-PK) as primary and colonoscopy as secondary screening test sounds more efficient with higher compliance than current CRC mass screening protocols. Recommendations for CRC mass screening are suggested for each risk population based on risk stratification. Serum M2-PK- may be developed as a promising CRC primary mass screening test. Sequential combination of serum biomarker such as M2-PK and colonoscopy can be a promising CRC mass screening protocol.

Biography :

Hong-Hong (Helen) Zhu obtained her Ph.D. in Epidemiology from Johns Hopkins University Bloomberg School of Public Health, M.Sc. from Clemson University, and MD from Zhejiang University. She has expertise in epidemiologic methods, application of epidemiologic methods in clinical medicine, public health and other health sciences, cancer and other chronic diseases prevention and control, toxicology, food and nutrition, and molecular medicine. She has a unique expertise in translating basic research into animal/tissue research and into clinical and population research and verse versa, interpreting clinical and population research results using biologic mechanisms from basic and animal/tissue research.

tempobet

tempobet giriş

tempobet giriş

süperbetin

tipobet yeni giriş adresi tipobet e yeni giriş tipobet güncel giriş adresi imajbet giriş adresi

mobilbahis giriş

arrow_upward arrow_upward